Figure 1.
Schematic presentation of the two-compartment cyclophosphamide model, one-compartment 4-hydroxycyclophosphamide model and one-compartment enzyme model. The enzyme model is linked to the drug model by cyclophosphamide concentrations stimulating the enzyme production rate and enzyme amount affecting the cyclophosphamide clearance.